A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer

Clinical trial NCT03735290 · TERMINATED

Trial details

NCT number: NCT03735290
Sponsor: Mendus
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Non-small Cell Lung Cancer

Start date: 2019-01-14
Primary completion: 2021-12-03
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.